Phase I clinical trial recruitment: assessing feasibility beyond database size
Return to all Astrum Insights Phase I clinical trial recruitment: assessing feasibility beyond database size What does volunteer database size tell sponsors about recruitment? A large volunteer database is useful for Phase I clinical trial recruitment, but its size alone is not enough to assess recruitment feasibility. Sponsors also need to understand how many potential […]
Why First-In-Human studies belong in a hospital
Return to all Astrum Insights Why First-In-Human studies belong in a hospital First-in-Human (FiH) studies involve administering a new investigational medicine to humans for the first time. Experienced teams, careful monitoring and immediate access to hospital services help manage uncertainty and support informed dosing decisions. What does this mean in practice? We spoke with our […]
The case for consistency
Return to all Astrum Insights The case for consistency Why retaining one CRO partner during all phases of clinical development drives better outcomes The journey from non-clinical and early phase research to market entry is complex and filled with challenges. To navigate this environment, companies must focus on maintaining a clear strategy that mitigates, to […]
Getting Phase I trials right first time
Return to all Astrum Insights Getting Phase I trials right first time How to ensure your Phase I trials comply with quality and regulatory expectations, long-term. Quality of clinical data, competitive timelines, and cost-effectiveness: these are just some of the numerous considerations that Biopharma and MedTech companies need to think about when conducting clinical studies. […]